Hesperidin Promotes Osteogenesis and Modulates Collagen Matrix Organization and Mineralization In Vitro and In Vivo

This study evaluated the direct effect of a phytochemical, hesperidin, on pre-osteoblast cell function as well as osteogenesis and collagen matrix quality, as there is little known about hesperidin’s influence in mineralized tissue formation and regeneration. Hesperidin was added to a culture of MC3T3-E1 cells at various concentrations. Cell proliferation, viability, osteogenic gene expression and deposited collagen matrix analyses were performed. Treatment with hesperidin showed significant upregulation of osteogenic markers, particularly with lower doses. Mature and compact collagen fibrils in hesperidin-treated cultures were observed by picrosirius red staining (PSR), although a thinner matrix layer was present for the higher dose of hesperidin compared to osteogenic media alone. Fourier-transform infrared spectroscopy indicated a better mineral-to-matrix ratio and matrix distribution in cultures exposed to hesperidin and confirmed less collagen deposited with the 100-µM dose of hesperidin. In vivo, hesperidin combined with a suboptimal dose of bone morphogenetic protein 2 (BMP2) (dose unable to promote healing of a rat mandible critical-sized bone defect) in a collagenous scaffold promoted a well-controlled (not ectopic) pattern of bone formation as compared to a large dose of BMP2 (previously defined as optimal in healing the critical-sized defect, although of ectopic nature). PSR staining of newly formed bone demonstrated that hesperidin can promote maturation of bone organic matrix. Our findings show, for the first time, that hesperidin has a modulatory role in mineralized tissue formation via not only osteoblast cell differentiation but also matrix organization and matrix-to-mineral ratio and could be a potential adjunct in regenerative bone therapies.     

Characterization, in vitro release and permeation studies of nicotine transdermal patches prepared from deproteinized natural rubber latex blends

The nicotine transdermal patches (NTPs) are available used for smoking cessation; however, they still should be developed for high efficacy and low cost. In this study, deproteinized natural rubber latex (DNRL) blended with hydroxypropylmethyl cellulose (HPMC) and dibutylphthalate (DBP) were used as matrix membrane for nicotine (NCT) delivery. Several techniques, i.e., FT-IR, XRD, DSC, and SEM were used to characterize the compatibility of each ingredient in the blended patches. A backing layer was used to protect NCT from volatilization. Five different types of backing layer were evaluated for their effects on in vitro release and skin permeation of NCT from the formulated matrix membranes. The backing layer with highest moisture vapor transmission rate (MVTR) and lowest oxygen transmission (OT) supposed to give higher NCT release and skin permeation due to increasing of skin hydration and its occlusive effect. The kinetic of in vitro release and permeation was demonstrated the monophasic slow release pattern which confirmed by first order and zero order kinetics, respectively. Therefore, the backing layer could be appropriated and used conveniently in the preparation of NTPs.     

In vitro study of the SBF and osteoblast-like cells on hydroxyapatite/chitosan–silica nanocomposite

Hydroxyapatite/chitosan–silica (HApCSi) nanocomposites were synthesized by co-precipitated method and their potential application as filler materials for bone regeneration were investigated in simulated body fluid (SBF). To study their biocompatibility, they were cultured with rat osteoblast-like UMR-106 cells for 3, 7, 14, and 21 days. Studies of the silica contents in chitosan matrix showed the presence of silinol (Si–OH) groups in CSi hybrid and their decrease after being composited with calcium phosphate (CaP) which is desirable for the formation of the apatite. XRD and TEM studies showed that the HAp formed in the CSi matrix were nanometer (20–40 nm) in size. Nanocomposites of HApCSi20 processed with 20%v/v silica whisker showed a micro hardness of 84.7 ± 3.3 MPa. Mineralization study in SBF showed the formation of apatite crystals on the HApCSi surface after being incubated for 7 days. In vitro biocompatibility, cell morphology, proliferation, and cell adhesion tests confirmed the osteoblast attachment and growth on the HApCSi20 surface. The density of cells and the production of calcium nodules on the substrate were seen to increase with increasing cultured time. The mechanical evaluation and in vitro experiment suggested that the use of HApCSi composite will lead to the formation of new apatite particles and thus be a potential implant material.     

Evaluation of cross-linked chitosan microparticles containing metronidazole for periodontitis treatment

The aims of this study were to find the optimal formulation for the preparation of metronidazole-loaded chitosan microparticles (MTZ-MPs) via an emulsion cross-linking process, and to compare the in vitro release of MTZ from hydrogels and films containing the drug in forms of MTZ-MPs and raw powders. The effects of emulsifier type and concentration, amount of cross-linking agent, cross-linking time, drug:chitosan ratio, form of drug adding and washing method on the properties of the MTZ-MPs were investigated. The results indicated that the optimal conditions for round and free-flowing MTZ-MPs with a high percentage of entrapped drug and preferable release profile were 1% of Span80 in soybean oil, 5% of glutaraldehyde based on chitosan solution, 30 min of cross-linking time, 1:1 drug:chitosan ratio, drug adding in form of ethanol solution and washing with hexane only. MTZ-MPs prepared from the optimal formulation were incorporated in mucoadhesive hydrogel and film. The release profiles of the drug from hydrogel and film containing MTZ-MPs were in prolong pattern compared with those containing drug powders. However, the hydrogels exhibited higher preferable pattern of release profile than the films. Therefore, the hydrogel containing MTZ-MPs was possible to be further clinically investigated for peridontitis treatment.     

A BEM-based domain meshless method for the analysis of Mindlin plates with general boundary conditions

In this paper, a BEM-based domain meshless method is developed for the analysis of moderately thick plates modeled by Mindlin’s theory which permits the satisfaction of three physical conditions along the plate boundary. The presented method is achieved using the concept of the analog equation of Katsikadelis. According to this concept, the original governing differential equations are replaced by three uncoupled Poisson’s equations with fictitious sources under the same boundary conditions. The fictitious sources are established using a technique based on BEM and approximated by radial basis functions series. The solution of the actual problem is obtained from the known integral representation of the potential problem. Thus, the kernels of the boundary integral equations are conveniently established and evaluated. The presented method has the advantages of the BEM in the sense that the discretization and integration are performed only on the boundary, and consequently Mindlin plates with general boundary conditions can be analyzed without difficulty. To illustrate the effectiveness, applicability as well as accuracy of the method, numerical results of various example problems are presented.     

Effect of process variables on the microencapsulation of vitamin A palmitate by gelatin-acacia coacervation

Microcapsules of vitamin A palmitate were prepared by gelatin-acacia complex coacervation. The effects of colloid mixing ratio, core-to-wall ratio, hardening agent, concentration of core solution, and drying method on the coacervation process and the properties of the microcapsules were investigated. The microcapsules of vitamin A palmitate were prepared using different weight ratios of gelatin and acacia, that is, 2:3, 1:1, and 3:2 under controlled conditions. The other factors studied were 1:1, 1:2, and 1:3 core-to-wall ratios; 30, 60, and 120 min of hardening time; 2, 5, and 10 ml of formaldehyde per 280 g of coacervation system as a hardening agent; and 30%, 40%, and 50% w/w vitamin A palmitate in corn oil as a core material. The drying methods used were air drying, hot air at 40°C, and freeze-drying. The results showed that spherical microcapsules were obtained for all conditions except for 30 min of hardening time, which did not result in microcapsules. The optimum conditions for free-flowing microcapsules with a high percentage of entrapped drug were 1:1 gelatin-to-acacia ratio and 1:2 core-to-wall ratio when hardening with 2 ml formaldehyde for 60 min and using 40% w/w vitamin A palmitate in corn oil as the core concentration. In addition, drying the microcapsules by freeze-drying provided microcapsules with excellent appearance.     

Enhancement of the skin permeation of clindamycin phosphate by Aerosol OT/1-butanol microemulsions

Microemulsions of water/isopropyl palmitate (IPP)/Aerosol OT (AOT)/1-butanol were developed as alternative formulations for topical delivery of clindamycin phosphate. Effect of AOT:1-butanol ratios on microemulsion region existence in the pseudoternary phase diagrams was investigated. The 2:1 AOT:1-butanol provided the largest microemulsion region. Five microemulsions of 1% w/w clindamycin phosphate were prepared and characterized. The permeation through human epidermis of the microemulsions was evaluated and compared with the 70% isopropanol solution using modified Franz diffusion cells. The drug permeation from all microemulsions was found to be significantly greater than that from the solution, indicating the enhancement of the skin permeation by the microemulsions. Within the same microemulsion type, the drug permeation increased with increasing the amount of AOT:1-butanol. The drug permeation from oil-in-water (o/w) microemulsions was relatively higher than that from water-in-oil (w/o) microemulsions. In addition, all microemulsions were stable for at least three months at 30 ± 1°C.     

Simplex Lattice Approach to Optimize Yields of Light Oil Products from Catalytic Cracking of Bio-Oil with Mixed Catalysts

Bio-oil is a potential product from the fast pyrolysis of biomass. However, it should be upgraded before being used in subsequent applications and corrosion prevention. In this work, crude bio-oil from fast pyrolysis of Jatropha curcas residues, which has many long-chain compounds, and a high content of carboxylic acid, was catalytically upgraded over mechanically mixed catalysts (normal ZSM-5 and Y-Re-16) in a fixed-bed reactor. The effects of the key parameters on the yields of light oil products were analyzed, including cracking temperature (350–500°C), reaction time (15–60?min), catalyst loading (10–25%), and mixture ratio between Y-Re-16 and ZSM-5 (10–70%). Experimental test cases were based on a simplex lattice design. The gas chromatograph-mass spectrometer (GC-MS) analysis showed that the catalytic cracking of crude bio-oil using mixed catalysts resulted in the successful formation of short-chain acid methyls. The employed analytical fit of the experimental data gave R² and the adjusted R² of 0.902 and 0.843, respectively. The optimized operation conditions to produce aliphatic hydrocarbons from mechanically mixed catalysts were found to be at 400°C, 15?min of reaction time, 15% of catalyst loading, and a mixture ratio of about 1:5.     

Biomarkers for Refractory Lupus Nephritis: A Microarray Study of Kidney Tissue

The prognosis of severe lupus nephritis (LN) is very different among individual patients. None of the current biomarkers can be used to predict the development of refractory LN. Because kidney histology is the gold standard for diagnosing LN, the authors hypothesize that molecular signatures detected in kidney biopsy tissue may have predictive value in determining the therapeutic response. Sixty-seven patients with biopsy-proven severely active LN by International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification III/IV were recruited. Twenty-three kidney tissue samples were used for RNA microarray analysis, while the remaining 44 samples were used for validation by real-time polymerase chain reaction (PCR) gene expression analysis. From hundreds of differential gene expressions in refractory LN, 12 candidates were selected for validation based on gene expression levels as well as relevant functions. The candidate biomarkers were members of the innate immune response molecules, adhesion molecules, calcium-binding receptors, and paracellular tight junction proteins. S100A8, ANXA13, CLDN19 and FAM46B were identified as the best kidney biomarkers for refractory LN, and COL8A1 was identified as the best marker for early loss of kidney function. These new molecular markers can be used to predict refractory LN and may eventually lead to novel molecular targets for therapy.